China's Latest Cybersecurity Proposal Could Heighten Scrutiny On Device, Drug Industries

18 Aug 2017

Medtech and biopharma are among key information infrastructure industries likely subject to additional security and reporting obligations under draft legislation, adding costs and even potentially causing business disruptions, legal experts say.

China's Cyberspace Administration proposed a key follow-on provision to the country's Cybersecurity Law which could directly impact the medical device and biopharma industry.

The draft, Key Information Infrastructure Protection decree, was open for public comments through Aug. 10.